Skip to main content
Print Save

Mepsevii Prices, Coupons and Patient Assistance Programs

Mepsevii (vestronidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Mucopolysaccharidosis Type VII.

The cost for Mepsevii intravenous solution (2 mg/mL) is around $2,705 for a supply of 5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Mepsevii prices

Intravenous Solution

Quantity Per unit Price
5 milliliters $541.04 $2,705.18

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Mepsevii Coupons, Copay Cards and Rebates

Mepsevii offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Mepsevii UltraCare Copay Assistance Program

Eligible commercially insured patients may be able to receive financial assistance to cover out-of-pockets costs for medicine and the cost of administration; for additional information contact the program at 888-756-8657.

Applies to:
Mepsevii
Number of uses:
Per prescription until program expires

Form more information phone: 888-756-8657 or Visit website

Patient Assistance & Copay Programs for Mepsevii

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: UltraCare Patient Assistance Program

Eligibility requirements:
  1. Determined case by case
  2. Not Required
  3. FDA-approved diagnosis
  4. Must be residing in the US or Puerto Rico
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Mepsevii (vestronidase alfa-vjbk) Injection; IV

More information please phone: 888-756-8657 Visit Website